A Study Evaluating the Effectiveness of AMG 334 Injection in Preventing Migraines in Adults Having Failed Other Therapies

PHASE3CompletedINTERVENTIONAL
Enrollment

246

Participants

Timeline

Start Date

March 20, 2017

Primary Completion Date

January 18, 2018

Study Completion Date

January 28, 2021

Conditions
Episodic Migraine
Interventions
BIOLOGICAL

AMG334 (70 mg) Pre-Filled Syringe (PFS)

Two injections of AMG 334 70 mg (equaling 140 mg total dose) will be administered via subcutaneous injection

BIOLOGICAL

Placebo Pre-Filled Syringe (PFS)

Subcutaneous injection of matching placebo

Trial Locations (59)

1011

Novartis Investigative Site, Lausanne

1090

Novartis Investigative Site, Vienna

Novartis Investigative Site, Brussels

1337

Novartis Investigative Site, Sandvika

2317

Novartis Investigative Site, Hamar

2600

Novartis Investigative Site, Glostrup Municipality

3000

Novartis Investigative Site, Leuven

3084

Novartis Investigative Site, Heidelberg

3500

Novartis Investigative Site, Hasselt

5330

Novartis Investigative Site, Bad Zurzach

8702

Novartis Investigative Site, Zollikon

9000

Novartis Investigative Site, Ghent

10435

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

13885

Novartis Investigative Site, Marseille

15125

Novartis Investigative Site, Marousi

16675

Novartis Investigative Site, Glyfada

18600

Novartis Investigative Site, Czech Republic

20100

Novartis Investigative Site, Turku

20133

Novartis Investigative Site, Milan

20251

Novartis Investigative Site, Hamburg

24149

Novartis Investigative Site, Kiel

28223

Novartis Investigative Site, Pozuelo de Alarcón

28942

Novartis Investigative Site, Fuenlabrada

39008

Novartis Investigative Site, Santander

40139

Novartis Investigative Site, Bologna

44787

Novartis Investigative Site, Bochum

45147

Novartis Investigative Site, Essen

47011

Novartis Investigative Site, Valladolid

50009

Novartis Investigative Site, Zaragoza

50139

Novartis Investigative Site, Florence

59037

Novartis Investigative Site, Lille

65191

Novartis Investigative Site, Wiesbaden

72076

Novartis Investigative Site, Tübingen

80138

Novartis Investigative Site, Napoli

81377

Novartis Investigative Site, München

90127

Novartis Investigative Site, Palermo

91054

Novartis Investigative Site, Erlangen

A 6020

Novartis Investigative Site, Innsbruck

120 00

Novartis Investigative Site, Prague

140 59

Novartis Investigative Site, Prague

00180

Novartis Investigative Site, Helsinki

00930

Novartis Investigative Site, Helsinki

06003

Novartis Investigative Site, Nice

D 33647

Novartis Investigative Site, Bielefeld

04107

Novartis Investigative Site, Leipzig

115 25

Novartis Investigative Site, Athens

00189

Novartis Investigative Site, Roma

6162 BG

Novartis Investigative Site, Sittard-Geleen

2333 ZA

Novartis Investigative Site, Leiden

6532 SZ

Novartis Investigative Site, Nijmegen

08035

Novartis Investigative Site, Barcelona

222 22

Novartis Investigative Site, Lund

114 33

Novartis Investigative Site, Stockholm

SE-751 85

Novartis Investigative Site, Uppsala

162 68

Novartis Investigative Site, Vällingby

BN2 5BE

Novartis Investigative Site, Brighton

ST46QG

Novartis Investigative Site, Stoke-on-Trent

SE5 9RS

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY